60 Degrees Pharmaceuticals (SXTP) Intangibles (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Intangibles of $243212.0 for Q1 2026, up 62.37% year-over-year from $149785.0 in Q1 2025, and down 28.27% quarter-over-quarter from $339050.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Intangibles (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Intangibles for 5 consecutive years, with $243212.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles rose 62.37% year-over-year to $243212.0; the TTM figure through Mar 2026 stood at $243212.0 (up 62.37% YoY), while the FY2025 annual figure was $339050.0, up 115.84% from the prior year.
- Intangibles eased to $243212.0 in Q1 2026 per SXTP's latest filing, from $339050.0 in the prior quarter.
- Across five years, Intangibles topped out at $339050.0 in Q4 2025 and bottomed at $143704.0 in Q2 2025.
- Historically, Intangibles has averaged $220610.5 across 5 years, with a median of $227258.0 in 2023.
- On a YoY basis, Intangibles climbed as much as 115.84% in 2025 and fell as far as 42.54% in 2025.
- 60 Degrees Pharmaceuticals' Intangibles stood at $164255.0 in 2022, then soared by 38.36% to $227258.0 in 2023, then sank by 30.88% to $157084.0 in 2024, then soared by 115.84% to $339050.0 in 2025, then slipped by 28.27% to $243212.0 in 2026.
- Business Quant data shows SXTP's Intangibles at $243212.0 in Q1 2026, $339050.0 in Q4 2025, and $258674.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 446,397.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243,212.00 |
| Dec 31, 2025 | 339,050.00 |
| Sep 30, 2025 | 258,674.00 |
| Jun 30, 2025 | 143,704.00 |
| Mar 31, 2025 | 149,785.00 |
| Dec 31, 2024 | 157,084.00 |
| Sep 30, 2024 | 264,351.00 |
| Jun 30, 2024 | 250,103.00 |
| Mar 31, 2024 | 217,417.00 |
| Dec 31, 2023 | 227,258.00 |
| Sep 30, 2023 | 225,047.00 |
| Jun 30, 2023 | 227,997.00 |
| Dec 31, 2022 | 164,255.00 |